Subscribe to Newsletter

Clinical Trials

Business & Regulation Digital Technologies

The Changing Landscape of Decentralized Clinical Trials

| Diane Leclerc | 2 min read

How technology is enabling new access to clinical trials for those without the means to participate in traditional methods

Discovery & Development Drug Discovery

The Speed of Success

| 4 min read

If used correctly, AI and ML expand our knowledge of biology and vastly improve the speed of success in the clinic.

Discovery & Development Clinical Trials

Harnessing AI for Pharma's Next Leap

| Tero Laulajainen | 3 min read

Discussing the finer points of AI as a catalyst for pharmaceutical innovation

Discovery & Development Clinical Trials

The Art of Prescreening

| 5 min read

How does prescreening improve clinical trials? Cara Brant, CEO of Clinical Trial Media, explains.

Discovery & Development Clinical Trials

Don’t Forget the Elderly

| Sharmeen Roy | 4 min read

Older adults are underrepresented in clinical trials. This needs to change.

Discovery & Development Clinical Trials

For Faster Trials, Improve Feasibility

| Christine Senn | 6 min read

The burden on clinical trials designers and healthcare professionals can only be eased by fixing a broken process: trial feasibility.

Discovery & Development Clinical Trials

Regeneron on the Digital Age of Clinical Trials

| 6 min read

The world is taking more interest in clinical trials. How are clinical trials adapting? Regeneron’s Bari Kowal keeps us updated.

Discovery & Development Clinical Trials

Clinical Arms

| 4 min read

Phesi CEO Gen Li discusses the impacts of the conflict between Russia and Ukraine on clinical trials

Discovery & Development Clinical Trials

Using Data to Advance Clinical Trials

| 4 min read

Veeva’s Richard Young looks back on breakthroughs in clinical trial technology and why the industry must continue to make trials more patient centric.

Discovery & Development Clinical Trials

Charting the Future of IBD Trials

| Deepika Khedekar | 5 min read

Acknowledging the shortcomings in IBD-related clinical trials and a potential holistic approach to overcoming them

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register